Medications
Resources
Basic InformationMore InformationLatest News
Health Tip: Packing Prescriptions for TravelDrug Errors Peak in July When New Docs StartFDA Warns Consumers Against Swallowing Topical BenadrylStudy Shows Some Anti-Seizure Meds Raise Suicide RiskU.S. Oftalmi Recalls Camolyn Eye Drops, Fisiolin Nasal DropsPrescriptions Translated to Spanish Could Be Hazardous to HealthTougher-to-Abuse Form of OxyContin ApprovedVaccines-By-Patch Good News for Needle-PhobicRifaximin Maintains Remission in Patients With Liver DiseaseMenstrual Cramps May Be Helped by New DrugNew Inhaled Insulin Shows Promise for DiabetesPlavix Can Help Cut Death Risk in Certain Heart PatientsFDA Asks Docs to Suspend Using Glaxo Rotavirus VaccineFDA Says High-Dose Simvastatin Ups Myopathy RiskHigh-Dose Zocor Boosts Muscle Injury Risk: FDAAvandia Researchers' Financial Ties QuestionedCarbaglu Approved for Rare Genetic DisorderACC: New Dual-Acting Drug Lowers Blood PressureNewer Blood Thinner Beats Plavix for Bypass PatientsArthritis Drug May Fight Diabetes, Too2 Drugs Fail to Prevent Diabetes in the OverweightFDA Adds Boxed Warning to Clopidogrel LabelThiazolidinediones Not Linked to Diabetic Macular EdemaYoung Kids to Benefit From Broader Pneumococcal VaccineBleeding Alert Sounded for Stroke DrugsHeartburn Drug Kapidex Renamed to DexilantLink Between Diabetes and Neuroleptic Drugs OutlinedResistance Likely to Develop With New Hepatitis C DrugsLasofoxifene Examined in Postmenopausal WomenSuccessor to Combination Pneumococcal Vaccine ApprovedMenveo Vaccine Approved for Bacterial MeningitisFDA: No Decision on Whether to Pull Diabetes Drug Avandia Off the MarketRituxan Approved for Chronic Lymphocytic LeukemiaNew Technology Could Widen Reach of VaccinesFDA Issues Warning on Key Asthma DrugsFDA Issues Maalox Total Relief WarningIbuprofen May Help Stave Off Parkinson'sFDA Tightens Controls on Anemia DrugsAdded Drug Aids MS Treatment'Fishy Smell' May Keep Patients From Diabetes DrugBotox May Prevent Some MigrainesAnother Study Refutes Vaccination-Autism LinkCrestor Approval ExpandedParoxetine May Compromise the Efficacy of TamoxifenNeedle Length May Affect Vaccination Results in ObeseDrug May Ease Cognitive Effects of Huntington'sGlaucoma Drugs May Play Role in Longer LifeH1N1 Vaccination Still Highly RecommendedThe Lancet Retracts Study Linking MMR Vaccine, AutismXiaflex Approved for Rare Hand Condition
Questions and AnswersLinksBook Reviews
Related Topics

Anxiety Disorders
Depression: Major Depression & Unipolar Varieties
Medical Disorders
Mental Disorders
Mental Health Professions

Contraceptive Depo-Provera May Weaken Bones

HealthDay News
by -- Randy Dotinga
Updated: Dec 23rd 2009

new article illustration

WEDNESDAY, Dec. 23 (HealthDay News) -- In a study of women who received the "birth control shot" -- also known as depot medroxyprogesterone acetate (Depo-Provera), nearly half lost at least 5 percent of their bone mineral density in the hip and lower spine within two years.

Women who were smokers, who had never given birth and who didn't consume much calcium were at highest risk, and they continued to experience significant losses in the third year of use, according to the report published in the January issue of Obstetrics & Gynecology.

"Bone mineral density loss is not a significant concern for all women" who use this method of birth control, said senior study author Dr. Abbey Berenson, professor in the department of obstetrics and gynecology and director of the Center for Interdisciplinary Research in Women's Health at the University of Texas Medical Branch at Galveston, in a university news release.

But, she added, "based on these findings, clinicians have the information they need to recommend basic behavior changes for high-risk women to minimize bone mineral density loss."

The two-year study included 95 patients who had the injection, and of those, 45 women lost at least 5 percent of bone mineral density in their lower backs and hips. Further research for another year in 27 of the study participants found that those at high risk lost even more bone mass.

In the United States, more than two million women use the injected contraceptive, according to background information in the news release.

More information

Learn more about bone density from the U.S. National Institutes of Health.




To Access Services
Call (815) 224-1610
24 hours a day
7 days a week

info@ncbhs.org

Outpatient Center Locations in Illinois:

  • LaSalle
  • Ottawa
  • Streator
  • Princeton
  • Canton
  • Macomb

powered by centersite dot net